| Product NDC: | 13668-006 |
| Proprietary Name: | Sertraline hydrochloride |
| Non Proprietary Name: | Sertraline hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; Sertraline hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13668-006 |
| Labeler Name: | Torrent Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077765 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070905 |
| Package NDC: | 13668-006-13 |
| Package Description: | 1300 TABLET, FILM COATED in 1 BOTTLE (13668-006-13) |
| NDC Code | 13668-006-13 |
| Proprietary Name | Sertraline hydrochloride |
| Package Description | 1300 TABLET, FILM COATED in 1 BOTTLE (13668-006-13) |
| Product NDC | 13668-006 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sertraline hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070905 |
| Marketing Category Name | ANDA |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | SERTRALINE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |